Treatments currently in use or in the final stages of clinical development include: Remdesivir (GS-5734), a Lopinavir/Ritonavir association (with or without Interferon 1ß), HCQ, anti-IL-6, Jakinibs or intravenous immunoglobulin are evaluated to treat COVID-19 [77]. This evidence concerns the gene IL6 and COVID-19.